| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jeffrey L Dupree, Douglas L Feinstei. Influence of diet on axonal damage in the EAE mouse model of multiple sclerosis. Journal of neuroimmunology. vol 322. 2019-10-03. PMID:29803554. |
in the current study we compared changes in axonal damage and myelin thickness in spinal cords of sham- and mog (myelin oligodendrocyte glycoprotein) peptide-immunized mice kept on a standard mouse chow (teklad 7012) versus ain-93 m chow which was developed for improved animal health. |
2019-10-03 |
2023-08-13 |
mouse |
| Matthew A J Chedrawe, Scott P Holman, Anna-Claire Lamport, Turgay Akay, George S Robertso. Pioglitazone is superior to quetiapine, clozapine and tamoxifen at alleviating experimental autoimmune encephalomyelitis in mice. Journal of neuroimmunology. vol 321. 2019-10-03. PMID:29957391. |
mice were immunized with an immunogenic peptide corresponding to amino acids 35-55 of the myelin oligodendrocyte glycoprotein (mog |
2019-10-03 |
2023-08-13 |
mouse |
| Franziska Di Pauli, Thomas Berge. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders? Frontiers in immunology. vol 9. 2019-10-03. PMID:30555462. |
a further extensively studied possible target structure is myelin oligodendrocyte glycoprotein (mog), found at the outermost surface of myelin sheaths and oligodendrocyte membranes. |
2019-10-03 |
2023-08-13 |
Not clear |
| Daniela Díaz-Lucena, María Gutierrez-Mecinas, Beatriz Moreno, José Lupicinio Martínez-Sánchez, Paula Pifarré, Agustina Garcí. Mechanisms Involved in the Remyelinating Effect of Sildenafil. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 13. issue 1. 2019-10-02. PMID:28776122. |
using myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis (eae) as a ms model, we previously showed that daily administration of sildenafil starting at peak disease rapidly ameliorates clinical symptoms while administration at symptoms onset prevents disease progression. |
2019-10-02 |
2023-08-13 |
mouse |
| Elise Allender, Harvinderjeet Deol, Sarah Schram, Kathleen J Maheras, Alexander Gow, Eleanor H Simpson, Fei Son. Neuregulin1 modulation of experimental autoimmune encephalomyelitis (EAE). Journal of neuroimmunology. vol 318. 2019-09-30. PMID:29534847. |
in myelin oligodendrocyte glycoprotein (mog)-induced eae, female double tg mice show delayed disease onset and reduced disease severity compared to male double tg as well as wild type littermates. |
2019-09-30 |
2023-08-13 |
mouse |
| Can Araman, Miriam E van Gent, Nico J Meeuwenoord, Nicole Heijmans, Mikkel H S Marqvorsen, Ward Doelman, Bart W Faber, Bert A 't Hart, Sander I Van Kastere. Amyloid-like Behavior of Site-Specifically Citrullinated Myelin Oligodendrocyte Protein (MOG) Peptide Fragments inside EBV-Infected B-Cells Influences Their Cytotoxicity and Autoimmunogenicity. Biochemistry. vol 58. issue 6. 2019-09-30. PMID:30513201. |
amyloid-like behavior of site-specifically citrullinated myelin oligodendrocyte protein (mog) peptide fragments inside ebv-infected b-cells influences their cytotoxicity and autoimmunogenicity. |
2019-09-30 |
2023-08-13 |
human |
| Can Araman, Miriam E van Gent, Nico J Meeuwenoord, Nicole Heijmans, Mikkel H S Marqvorsen, Ward Doelman, Bart W Faber, Bert A 't Hart, Sander I Van Kastere. Amyloid-like Behavior of Site-Specifically Citrullinated Myelin Oligodendrocyte Protein (MOG) Peptide Fragments inside EBV-Infected B-Cells Influences Their Cytotoxicity and Autoimmunogenicity. Biochemistry. vol 58. issue 6. 2019-09-30. PMID:30513201. |
there is evidence that citrullination protects an immunodominant peptide of human myelin oligodendrocyte glycoprotein (mog |
2019-09-30 |
2023-08-13 |
human |
| Vanderson Carvalho Neri, Maria Filomena Xavier, Priscila Oliveira Barros, Cleonice Melo Bento, Romain Marignier, Regina Papais Alvareng. Case Report: Acute Transverse Myelitis after Zika Virus Infection. The American journal of tropical medicine and hygiene. vol 99. issue 6. 2019-09-13. PMID:30277201. |
this patient had serum positivity for autoantibodies against myelin oligodendrocyte glycoprotein (mog), a specific antibody against the myelin sheath. |
2019-09-13 |
2023-08-13 |
Not clear |
| John J Chen, W Oliver Tobin, Masoud Majed, Jiraporn Jitprapaikulsan, James P Fryer, Jacqueline A Leavitt, Eoin P Flanagan, Andrew McKeon, Sean J Pittoc. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial. JAMA ophthalmology. vol 136. issue 4. 2019-09-12. PMID:29470571. |
autoantibodies to aquaporin-4 (aqp4) and myelin oligodendrocyte glycoprotein (mog) are recently established biomarkers of autoimmune optic neuritis whose frequency and accompanying phenotype, especially for mog-igg, are still being characterized. |
2019-09-12 |
2023-08-13 |
Not clear |
| Vladislav Yakimov, Felix Schweiger, Jiangshan Zhan, Newshan Behrangi, Anja Horn, Christoph Schmitz, Tanja Hochstrasser, Markus Kip. Continuous cuprizone intoxication allows active experimental autoimmune encephalomyelitis induction in C57BL/6 mice. Histochemistry and cell biology. vol 152. issue 2. 2019-09-06. PMID:31016368. |
here, we describe that in spite of its immunosuppressive effects, a continuous intoxication with cuprizone allows the induction of active experimental autoimmune encephalomyelitis (eae) by myelin oligodendrocyte glycoprotein (mog |
2019-09-06 |
2023-08-13 |
mouse |
| Jiraporn Jitprapaikulsan, John J Chen, Eoin P Flanagan, W Oliver Tobin, Jim P Fryer, Brian G Weinshenker, Andrew McKeon, Vanda A Lennon, Jacqueline A Leavitt, Jan-Mendelt Tillema, Claudia Lucchinetti, B Mark Keegan, Orhun Kantarci, Cheryl Khanna, Sarah M Jenkins, Grant M Spears, Jessica Sagan, Sean J Pittoc. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis. Ophthalmology. vol 125. issue 10. 2019-09-05. PMID:29716788. |
to determine the aquaporin-4 and myelin oligodendrocyte glycoprotein (mog) immunoglobulin g (igg) serostatus and visual outcomes in patients with recurrent optic neuritis (ron) initially seeking treatment. |
2019-09-05 |
2023-08-13 |
Not clear |
| Sanaz Mami, Farshid Yeganeh, Elnaz Farahani, Ali Anissian, Mustafa Haji Molla Hosein. Chitin Micro Particles Regulate Splenocytes Immune Response in Experimental Autoimmune Encephalomyelitis. Iranian journal of allergy, asthma, and immunology. vol 18. issue 2. 2019-08-27. PMID:31066255. |
to verify whether cmps could indeed up-regulate il-10/ifn-γ axis, isolated spleen cells from the myelin oligodendrocyte glycoprotein (mog) induced experimental autoimmune encephalomyelitis (eae) mice were cultured in the presence of mog peptide and/or cmps. |
2019-08-27 |
2023-08-13 |
mouse |
| Sudarshini Ramanathan, Gina L O'grady, Stephen Malone, Claire G Spooner, David A Brown, Deepak Gill, Fabienne Brilot, Russell C Dal. Isolated seizures during the first episode of relapsing myelin oligodendrocyte glycoprotein antibody-associated demyelination in children. Developmental medicine and child neurology. vol 61. issue 5. 2019-08-26. PMID:30221764. |
myelin oligodendrocyte glycoprotein (mog) antibodies have a strong association with acute disseminated encephalomyelitis (adem) in children, and bilateral and recurrent optic neuritis in children and adults. |
2019-08-26 |
2023-08-13 |
Not clear |
| Toshikazu Baba, Koji Shinoda, Mitsuru Watanabe, Shoko Sadashima, Dai Matsuse, Noriko Isobe, Ryo Yamasaki, Kimihiko Kaneko, Toshiyuki Takahashi, Toru Iwaki, Jun-Ichi Kir. MOG antibody disease manifesting as progressive cognitive deterioration and behavioral changes with primary central nervous system vasculitis. Multiple sclerosis and related disorders. vol 30. 2019-08-26. PMID:30738279. |
we report a 60-year-old male with anti-myelin oligodendrocyte glycoprotein (mog) antibody who developed progressive cognitive deterioration and behavioral changes, with no other focal signs, over 9 months. |
2019-08-26 |
2023-08-13 |
Not clear |
| Vanessa de Luca, Akemi Martins Higa, Camila Malta Romano, Giovanni Pimenta Mambrini, Luís Antonio Peroni, Francisco Trivinho-Strixino, Fabio Lima Leit. Cross-reactivity between myelin oligodendrocyte glycoprotein and human endogenous retrovirus W protein: nanotechnological evidence for the potential trigger of multiple sclerosis. Micron (Oxford, England : 1993). vol 120. 2019-08-21. PMID:30802755. |
experimental evidence supports the reactivity of autoantibodies against components of myelin sheath including the myelin oligodendrocyte glycoprotein (mog). |
2019-08-21 |
2023-08-13 |
human |
| Takeshi Imai, Souichirou Shibata, Kensuke Shinohara, Kenzo Sakurai, Masahiro Horiuchi, Yasuhiro Hasegaw. [Longitudinally extensive transverse myelitis involving fifteen vertebral bodies positive for anti-myelin oligodendrocyte glycoprotein (MOG) antibody: a case report]. Rinsho shinkeigaku = Clinical neurology. vol 59. issue 6. 2019-08-21. PMID:31142714. |
[longitudinally extensive transverse myelitis involving fifteen vertebral bodies positive for anti-myelin oligodendrocyte glycoprotein (mog) antibody: a case report]. |
2019-08-21 |
2023-08-13 |
Not clear |
| Melania Spadaro, Stephan Winklmeier, Eduardo Beltrán, Caterina Macrini, Romana Höftberger, Elisabeth Schuh, Franziska S Thaler, Lisa Ann Gerdes, Sarah Laurent, Ramona Gerhards, Simone Brändle, Klaus Dornmair, Constanze Breithaupt, Markus Krumbholz, Markus Moser, Gurumoorthy Krishnamoorthy, Frits Kamp, Dieter Jenne, Reinhard Hohlfeld, Tania Kümpfel, Hans Lassmann, Naoto Kawakami, Edgar Mein. Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein. Annals of neurology. vol 84. issue 2. 2019-08-20. PMID:30014603. |
autoantibodies against myelin oligodendrocyte glycoprotein (mog) occur in a proportion of patients with inflammatory demyelinating diseases of the central nervous system (cns). |
2019-08-20 |
2023-08-13 |
human |
| O Aktas, M P Wattjes, M Stangel, H-P Hartun. [Diagnosis of multiple sclerosis: revision of the McDonald criteria 2017]. Der Nervenarzt. vol 89. issue 12. 2019-08-13. PMID:29876600. |
finally, future studies will have to provide a definition for secondary progressive ms courses and clarify how to handle diseases characterized by antibodies against myelin oligodendrocyte glycoprotein (mog) or patients with radiologically isolated syndrome (ris), i. e. |
2019-08-13 |
2023-08-13 |
Not clear |
| Ray Wynford-Thomas, Anu Jacob, Valentina Tomassin. Neurological update: MOG antibody disease. Journal of neurology. vol 266. issue 5. 2019-08-12. PMID:30569382. |
myelin oligodendrocyte glycoprotein (mog) antibody disease (mog-ad) is now recognised as a nosological entity with specific clinical and paraclinical features to aid early diagnosis. |
2019-08-12 |
2023-08-13 |
Not clear |
| Sara Salama, Santiago Pardo, Michael Lev. Clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder. Multiple sclerosis and related disorders. vol 30. 2019-08-09. PMID:30825703. |
serological antibodies against myelin oligodendrocyte glycoprotein (mog) are associated with a relapsing autoimmune demyelinating disease of the central nervous system. |
2019-08-09 |
2023-08-13 |
Not clear |